Last reviewed · How we verify
NCT05295537: PEREUS
Percutaneous Versus Endoscopic Ultrasound-guided Liver Biopsy (PEREUS)
NA trial testing PERCUTANEOUS LIVER BIOPSY (PLB) in Liver Diseases in 92 participants. Completed in 1 December 2022.
1 September 2022
Quick facts
| Lead sponsor | Hospital Clinico Universitario de Santiago |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 92 |
| Start date | 19 January 2022 |
| Primary completion | 1 September 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- PERCUTANEOUS LIVER BIOPSY (PLB)
- ENDOSCOPIC ULTRASOUND GUIDED LIVER BIOPSY (EUS-LB)
Conditions studied
- Liver Diseases — all drugs for Liver Diseases →
Sponsor
Hospital Clinico Universitario de Santiago
Who can join
18 and older, any sex, with Liver Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Although the use of liver biopsy (LB) has decreased with the emerging non-invasive markers and techniques to evaluate liver fibrosis, histopathologic examination of liver tissue is necessary to confirm the type of liver injury. The aim of our study is to compare two methods for obtaining histological material from the liver: the percutaneous liver biopsy (PLB) and the Endoscopic ultrasound (EUS) guided liver biopsy (EUS-LB)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05295537
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Diseases
Currently open trials in the same condition.
- NCT07400289 — Development of a FibroScan Liver Examination Using a Single Probe · NA · recruiting
- NCT07150624 — The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine · Phase 4 · recruiting
- NCT06871111 — The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial · Phase 1 · recruiting
- NCT06874296 — Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time · NA · recruiting
- NCT07053488 — CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection · Phase 1, PHASE2 · recruiting
Other Hospital Clinico Universitario de Santiago trials
Trials by the same sponsor.
- NCT07495436 — Video Versus Direct Laryngoscopy for Tracheal Intubation in Pediatric Surgery · NA · not yet recruiting
- NCT07347158 — Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiet · NA · enrolling by invitation
- NCT06401486 — DOuble-Lumen Intubation With VIdeolaryngoscopy · NA · completed
- NCT06725966 — Personalized Treatment of Refractory BPPV · NA · recruiting
- NCT06322719 — Hyperangulated vs Macintosh Blades for Intubation With Videolaryngoscopy in ICU · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05295537 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Clinico Universitario de Santiago
- Last refreshed: 1 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05295537.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing